Drug‐Coated Balloons Versus Drug‐Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC‐CAGEFREE I Trial
Catheterization and Cardiovascular Interventions · 2026-08 · 108 (2) · 473-482
DOI: 10.1002/ccd.70679 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 27.05.2026. Verfasst von Yuehao Lv und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Angioplasty, Balloon, Coronary, Coronary Artery Disease, Coated Materials, Biocompatible. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Xijing Hospital, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Shenqi Medical.
Abstract (Originalsprache)
Background
For long coronary lesions, drug‐coated balloons (DCBs) might be an attractive alternative compared with drug‐eluting stents (DES); however, supporting evidence remains scarce.
Aims
To compare the efficacy of DCBs versus DES for treating long de novo coronary lesions.
Methods
REC‐CAGEFREE I was a non‐inferiority trial conducted at 43 sites in China, which randomized 2272 patients to paclitaxel‐coated balloon angioplasty with the option of rescue stenting or sirolimus‐eluting stents for treating de novo lesions, regardless of vessel diameter. In this pre‐specified subgroup analysis, patients were stratified by quantitative coronary angiography‐assessed lesion length into short (< 20 mm) and long (≥ 20 mm) groups. The primary endpoint was a device‐oriented composite endpoint (DoCE, including cardiovascular death, target vessel myocardial infarction, or clinically and physiologically‐indicated target lesion revascularization) at 3 years.
Results
2,223 (97.8%) participants with available angiograms were included, of which 302 (13.6%) had long lesions and 1921 (86.4%) had short lesions. At 3 years, DoCE occurred in 24/302 (8.0%) and 121/1921 (6.3%) patients in long and short groups, respectively. In the long lesions group, DoCE occurred in 14/121 (11.6%) and 10/181 (5.6%) in the DCBs and DES groups, respectively (HR IPTW : 2.46, 95% CI: 1.07–5.67, p = 0.034). In the short lesions group, DoCE occurred in 75/983 (7.7%) and 46/938 (4.9%) in the DCBs and DES groups, respectively (HR IPTW : 1.52, 95% CI: 1.03–2.22, p = 0.033). No significant interaction was observed between lesion length and DES/DCBs (P interaction = 0.460).
Conclusion
DCBs were associated with a higher risk of DoCE compared to DES for treating de novo lesions, regardless of lesion length.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
- Department of Cardiology, The First Hospital of Kunming, Kunming, China.
- Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
- Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Cardiology, Tianjin Fourth Central Hospital, Tianjin, China.
ORCID-Profile: Xiongwei Bai, Yanqing Wu, Xingqiang He, Patrick W Serruys, Chao Gao
Förderung
- Xijing Hospital
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Shenqi Medical
- Medisets
Zitieren
APA
Lv, Y., Yang, F., Bai, X., Wang, H., Wu, Y., Fang, Z., Zhou, J., Gao, H., Hu, T., Sun, D., Wang, Q., Yin, Z., Wen, S., Jin, Y., Hong, L., Liu, J., Fu, G., Zhang, R., He, X., …, & Gao, C. (2026). Drug‐Coated Balloons Versus Drug‐Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC‐CAGEFREE I Trial. Catheterization and Cardiovascular Interventions, 108(2), 473-482. https://doi.org/10.1002/ccd.70679
Vancouver
Lv Y, Yang F, Bai X, Wang H, Wu Y, Fang Z, et al. Drug‐Coated Balloons Versus Drug‐Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC‐CAGEFREE I Trial. Catheterization and Cardiovascular Interventions. 2026;108(2):473-482. doi:10.1002/ccd.70679
BibTeX
@article{Lv2026,
author = {Lv, Yuehao and Yang, Feng and Bai, Xiongwei and Wang, Hua and Wu, Yanqing and Fang, Zhenfei and Zhou, Jingyu and Gao, Haokao and Hu, Tao and Sun, Dongdong and Wang, Qiong and Yin, Zhiyong and Wen, Shangyu and Jin, Yuanzhe and Hong, Lang and Liu, Jianzheng and Fu, Guotao and Zhang, Ruining and He, Xingqiang and Zhu, Bin and Jiang, Zhiwei and Xia, Jielai and Capodanno, Davide and Garg, Scot and Onuma, Yoshinobu and Wang, Duolao and Serruys, Patrick W and Tao, Ling and Gao, Chao},
title = {Drug‐Coated Balloons Versus Drug‐Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC‐CAGEFREE I Trial},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {108},
number = {2},
pages = {473--482},
doi = {10.1002/ccd.70679}
}
EUVIMED